Medical management of aortic disease in children with Marfan syndrome
- 1 October 2018
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pediatrics
- Vol. 30 (5) , 639-644
Abstract
Purpose of review Marfan syndrome (MFS) is the most common cause of aortic aneurysm in children and is associated with premature mortality. Whereas surgical therapy remains the primary treatment to prevent aortic complications, medical therapy may slow or prevent aortic growth. Pediatricians and pediatric cardiologists should become familiar with the diagnosis and management of MFS. This review focuses on the medical management for the most important life-threatening manifestation of MFS, thoracic aortic disease. Recent findings Several large-scale clinical trials and one meta-analysis have been reported comparing angiotensin receptors blockers with the standard therapy, beta blockers. Summary From the assembled evidence described in this review, beta blockers and angiotensin receptors blockers show clinical equivalence and either class of agent may be an appropriate choice for the medical management of aortic growth in children with MFS.Keywords
This publication has 18 references indexed in Scilit:
- Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan SyndromeJACC, 2015
- The revised Ghent nosology for the Marfan syndrome: Table 1Journal of Medical Genetics, 2010
- 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic DiseaseJACC, 2010
- Effect of Beta-Blockade on Ascending Aortic Dilatation in Children With the Marfan SyndromeThe American Journal of Cardiology, 2007
- Aneurysm Syndromes Caused by Mutations in the TGF-β ReceptorNew England Journal of Medicine, 2006
- Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan SyndromeScience, 2006
- Aortic root replacement in 271 Marfan patients: a 24-year experienceThe Annals of Thoracic Surgery, 2002
- Replacement of the Aortic Root in Patients with Marfan's SyndromeNew England Journal of Medicine, 1999
- Progression of Aortic Dilatation and the Benefit of Long-Term β-Adrenergic Blockade in Marfan's SyndromeNew England Journal of Medicine, 1994
- The Cardiovascular Aspects of Marfan's Syndrome: A Heritable Disorder of Connective TissueCirculation, 1955